发明授权
- 专利标题： Therapeutic agents for glomerulosclerosis
- 专利标题（中）： 肾小球硬化症治疗剂
-
申请号： US10314389申请日： 2002-12-09
-
公开(公告)号： US06864247B2公开(公告)日： 2005-03-08
- 发明人: Toshio Doi
- 申请人： Toshio Doi
- 代理机构： Browdy and Neimark, P.L.L.C.
- 优先权： JP11-128566 19990510
- 主分类号： A61K31/593
- IPC分类号： A61K31/593 ; A61P13/12 ; A01N45/00
摘要：
An object of the present invention is to provide pharmaceutical compositions for inhibiting mesangial cell proliferation or mesangial matrix production without causing hypercalcemia.According to the present invention, therapeutic agents for glomerulosclerosis containing 1α,3β-dihydroxy-20α-(3-hydroxy-3-methylbutyloxy)-9,10-seco-5,7,10 (19)-pregnatriene as an active ingredient are provided.
公开/授权文献
- US20030083320A1 Therapeutic agents for glomerulosclerosis 公开/授权日：2003-05-01
信息查询
